Trial reportAmerican journal of Alzheimer's disease and other dementias2011
A novel technology to screen for cognitive impairment in the elderly.
Trial report in American journal of Alzheimer's disease and other dementias, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00454454 (Display Enhanced TEsting for Cognitive Impairment and Traumatic Brain Injury), which is not on this map. Cited by 11 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Display Enhanced TEsting for Cognitive Impairment and Traumatic Brain Injury
Who cites it
11 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Digital Tools for Mild Cognitive Impairment: A Systematic Review and Meta-analysis of Diagnostic Accuracy and Methodological Challenges.Neuropsychology review · 2026Pooled it
- eHealth tools to assess the neurological function for research, in absence of the neurologist: a systematic review, part II (hardware).Journal of neurology · 2025Pooled it
- Mini-Cog for the detection of dementia within a secondary care setting.The Cochrane database of systematic reviews · 2021Pooled it
- Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.The Cochrane database of systematic reviews · 2019Pooled it
- Brief cognitive screening instruments for early detection of Alzheimer's disease: a systematic review.Alzheimer's research & therapy · 2019Pooled it
- An Automated Virtual Reality Program Accurately Diagnoses HIV-Associated Neurocognitive Disorders in Older People With HIV.Open forum infectious diseases · 2023Article
- A Novel Neuropsychological Tool for Immersive Assessment of Concussion and Correlation with Subclinical Head Impacts.Neurotrauma reports · 2021Article
- Implementing Remote Memory Clinics to Enhance Clinical Care During and After COVID-19.Frontiers in psychiatry · 2020Article
- Validation of SATURN, a free, electronic, self-administered cognitive screening test.Alzheimer's & dementia (New York, N. Y.) · 2020Article
- Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.Journal of neurovirology · 2016Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTraditional evaluation of mild cognitive impairment (MCI) can be costly, time consuming, and impractical for widespread screening. DETECT is a portable device developed to rapidly perform cognitive testing in diverse settings. This study compares DETECT with formal clinical assessment.
methodsA prospective cross-sectional comparison of the DETECT device versus an expert neuropsychologist's assessment (NPA). A total of 405 participants ≥65 years old, recruited from geriatric clinics and retirement facilities, completed both DETECT and NPA. Multivariable logistic regression methods were used to evaluate the degree of correlation between DETECT testing and the NPA diagnosis.
resultsPredictive modeling demonstrated very good ability to discriminate between normal, MCI, and dementia per the NPA reference standard using DETECT subtests (c = 0.85 for any impairment; c = 0.99 for dementia).
conclusionDETECT scores closely correlate with NPA. DETECT can identify and discriminate between normal, MCI, and dementia and could be incorporated as a screener for MCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.